Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors - P&T Community -BoardProspects

Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors

P&T Community Jul 2 2019 BoardMoves

SAN DIEGO, July 2, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the appointment of Kathy Rouan, Ph.D., to its board of directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Neon Therapeutics Appoints Industry Veteran Robert Bazemore to its Board of Directors also published in P&T Community
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- IASO BioMed Announces Addition of Four Members to Its Scientific Advisory Board also published in P&T Community
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- The Future Of Clean Beauty Is Female: Maureen Chiquet, Former Global CEO Of Chanel, Joins Credo Board Of Directors also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned